303 related articles for article (PubMed ID: 30068552)
1. Agonistic β-Klotho antibody mimics fibroblast growth factor 21 (FGF21) functions.
Min X; Weiszmann J; Johnstone S; Wang W; Yu X; Romanow W; Thibault S; Li Y; Wang Z
J Biol Chem; 2018 Sep; 293(38):14678-14688. PubMed ID: 30068552
[TBL] [Abstract][Full Text] [Related]
2. Understanding the physical interactions in the FGF21/FGFR/β-Klotho complex: structural requirements and implications in FGF21 signaling.
Yie J; Wang W; Deng L; Tam LT; Stevens J; Chen MM; Li Y; Xu J; Lindberg R; Hecht R; Véniant M; Chen C; Wang M
Chem Biol Drug Des; 2012 Apr; 79(4):398-410. PubMed ID: 22248288
[TBL] [Abstract][Full Text] [Related]
3. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
[TBL] [Abstract][Full Text] [Related]
4. The FGF21 Receptor Signaling Complex: Klothoβ, FGFR1c, and Other Regulatory Interactions.
Kilkenny DM; Rocheleau JV
Vitam Horm; 2016; 101():17-58. PubMed ID: 27125737
[TBL] [Abstract][Full Text] [Related]
5. FGF19, FGF21, and an FGFR1/β-Klotho-Activating Antibody Act on the Nervous System to Regulate Body Weight and Glycemia.
Lan T; Morgan DA; Rahmouni K; Sonoda J; Fu X; Burgess SC; Holland WL; Kliewer SA; Mangelsdorf DJ
Cell Metab; 2017 Nov; 26(5):709-718.e3. PubMed ID: 28988823
[TBL] [Abstract][Full Text] [Related]
6. A biparatopic agonistic antibody that mimics fibroblast growth factor 21 ligand activity.
Shi SY; Lu YW; Liu Z; Stevens J; Murawsky CM; Wilson V; Hu Z; Richards WG; Michaels ML; Zhang J; Yan W; Li Y
J Biol Chem; 2018 Apr; 293(16):5909-5919. PubMed ID: 29483191
[TBL] [Abstract][Full Text] [Related]
7. Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity.
Kuzina ES; Ung PM; Mohanty J; Tome F; Choi J; Pardon E; Steyaert J; Lax I; Schlessinger A; Schlessinger J; Lee S
Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7819-7824. PubMed ID: 30944224
[TBL] [Abstract][Full Text] [Related]
8. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
[TBL] [Abstract][Full Text] [Related]
9. Heparin is essential for optimal cell signaling by FGF21 and for regulation of βKlotho cellular stability.
An SJ; Mohanty J; Tome F; Suzuki Y; Lax I; Schlessinger J
Proc Natl Acad Sci U S A; 2023 Feb; 120(7):e2219128120. PubMed ID: 36745784
[TBL] [Abstract][Full Text] [Related]
10. FGF21 N- and C-termini play different roles in receptor interaction and activation.
Yie J; Hecht R; Patel J; Stevens J; Wang W; Hawkins N; Steavenson S; Smith S; Winters D; Fisher S; Cai L; Belouski E; Chen C; Michaels ML; Li YS; Lindberg R; Wang M; Véniant M; Xu J
FEBS Lett; 2009 Jan; 583(1):19-24. PubMed ID: 19059246
[TBL] [Abstract][Full Text] [Related]
11. TNF-α represses β-Klotho expression and impairs FGF21 action in adipose cells: involvement of JNK1 in the FGF21 pathway.
Díaz-Delfín J; Hondares E; Iglesias R; Giralt M; Caelles C; Villarroya F
Endocrinology; 2012 Sep; 153(9):4238-45. PubMed ID: 22778214
[TBL] [Abstract][Full Text] [Related]
12. FGF21 can be mimicked in vitro and in vivo by a novel anti-FGFR1c/β-Klotho bispecific protein.
Smith R; Duguay A; Bakker A; Li P; Weiszmann J; Thomas MR; Alba BM; Wu X; Gupte J; Yang L; Stevens J; Hamburger A; Smith S; Chen J; Komorowski R; Moore KW; Véniant MM; Li Y
PLoS One; 2013; 8(4):e61432. PubMed ID: 23630589
[TBL] [Abstract][Full Text] [Related]
13. Treating diabetes and obesity with an FGF21-mimetic antibody activating the βKlotho/FGFR1c receptor complex.
Foltz IN; Hu S; King C; Wu X; Yang C; Wang W; Weiszmann J; Stevens J; Chen JS; Nuanmanee N; Gupte J; Komorowski R; Sekirov L; Hager T; Arora T; Ge H; Baribault H; Wang F; Sheng J; Karow M; Wang M; Luo Y; McKeehan W; Wang Z; Véniant MM; Li Y
Sci Transl Med; 2012 Nov; 4(162):162ra153. PubMed ID: 23197570
[TBL] [Abstract][Full Text] [Related]
14. FGF21 regulates metabolism and circadian behavior by acting on the nervous system.
Bookout AL; de Groot MH; Owen BM; Lee S; Gautron L; Lawrence HL; Ding X; Elmquist JK; Takahashi JS; Mangelsdorf DJ; Kliewer SA
Nat Med; 2013 Sep; 19(9):1147-52. PubMed ID: 23933984
[TBL] [Abstract][Full Text] [Related]
15. A systematic dissection of sequence elements determining β-Klotho and FGF interaction and signaling.
Shi SY; Lu YW; Richardson J; Min X; Weiszmann J; Richards WG; Wang Z; Zhang Z; Zhang J; Li Y
Sci Rep; 2018 Jul; 8(1):11045. PubMed ID: 30038432
[TBL] [Abstract][Full Text] [Related]
16. α-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling.
Chen G; Liu Y; Goetz R; Fu L; Jayaraman S; Hu MC; Moe OW; Liang G; Li X; Mohammadi M
Nature; 2018 Jan; 553(7689):461-466. PubMed ID: 29342138
[TBL] [Abstract][Full Text] [Related]
17. FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue.
Markan KR; Naber MC; Small SM; Peltekian L; Kessler RL; Potthoff MJ
Mol Metab; 2017 Jun; 6(6):602-610. PubMed ID: 28580290
[TBL] [Abstract][Full Text] [Related]
18. Paracrine-endocrine FGF chimeras as potent therapeutics for metabolic diseases.
Zhao L; Niu J; Lin H; Zhao J; Liu Y; Song Z; Xiang C; Wang X; Yang Y; Li X; Mohammadi M; Huang Z
EBioMedicine; 2019 Oct; 48():462-477. PubMed ID: 31631034
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and Distribution of Klothoβ (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex.
Ming AY; Yoo E; Vorontsov EN; Altamentova SM; Kilkenny DM; Rocheleau JV
J Biol Chem; 2012 Jun; 287(24):19997-20006. PubMed ID: 22523080
[TBL] [Abstract][Full Text] [Related]
20. A Novel Fc-FGF21 With Improved Resistance to Proteolysis, Increased Affinity Toward β-Klotho, and Enhanced Efficacy in Mice and Cynomolgus Monkeys.
Stanislaus S; Hecht R; Yie J; Hager T; Hall M; Spahr C; Wang W; Weiszmann J; Li Y; Deng L; Winters D; Smith S; Zhou L; Li Y; Véniant MM; Xu J
Endocrinology; 2017 May; 158(5):1314-1327. PubMed ID: 28324011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
